Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C163 - Neurologic Complications of Novel Anti-neoplastic Therapies Including Immunotherapy

Wednesday 04/26/23
01:00 PM - 03:00 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Yazmin Odia, MD, FAAN, MS
Neuro-oncology
Participants should become familiar with the distinct types of anti-neoplastic therapies, including cytotoxic, biologic, hormone, immunotherapy, radiation and other multimodal therapies, and their unique neurologic complications, as well as understand the underlying mechanisms of actions, interpret clinical and radiographic manifestations, and manage the neurological toxicities relative to the distinct types of anti-neoplastic therapies.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM EST Introduction Introduction to Course and Novel Cancer Therapies
Yazmin Odia, MD, FAAN, MS
01:05 PM - 01:35 PM EST Speaker Complications of Cytotoxic, Biologic, and Hormone Therapies
Na Tosha N. Gatson, MD, PhD, FAAN
01:35 PM - 02:05 PM EST Speaker Complications of Immunotherapies
Reena Parada Thomas, MD, PhD
02:05 PM - 02:45 PM EST Speaker Complications of Radiation and Multimodal Therapies
Yazmin Odia, MD, FAAN, MS
02:45 PM - 03:00 PM EST Speaker Case Panel Discussions
Yazmin Odia, MD, FAAN, MS, Na Tosha N. Gatson, MD, PhD, FAAN, Reena Parada Thomas, MD, PhD
Faculty Disclosures
Yazmin Odia, MD, FAAN, MS Dr. Odia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PharPoint. Dr. Odia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GammaTile.
Na Tosha N. Gatson, MD, PhD, FAAN Dr. Gatson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure, Ltd. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure .
Reena Parada Thomas, MD, PhD The institution of Dr. Thomas has received research support from NIH. The institution of Dr. Thomas has received research support from Health Resources & Services Administration. The institution of Dr. Thomas has received research support from California Institute of Regenerative Medicine. Dr. Thomas has received intellectual property interests from a discovery or technology relating to health care.